OncLive: Dr. Mesa on the Emergence of JAK Inhibitors in Myelofibrosis

In this interview, Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses the emergence of JAK inhibitors in myelofibrosis.

Watch the interview. 



Share This Article!
Article Categories: Cancer, In the News